SYRE
Price
$17.71
Change
-$0.29 (-1.61%)
Updated
Jun 12 closing price
Capitalization
1.09B
48 days until earnings call
VTYX
Price
$2.49
Change
+$0.05 (+2.05%)
Updated
Jun 12 closing price
Capitalization
177.19M
55 days until earnings call
Interact to see
Advertisement

SYRE vs VTYX

Header iconSYRE vs VTYX Comparison
Open Charts SYRE vs VTYXBanner chart's image
Spyre Therapeutics
Price$17.71
Change-$0.29 (-1.61%)
Volume$888.81K
Capitalization1.09B
Ventyx Biosciences
Price$2.49
Change+$0.05 (+2.05%)
Volume$1.57M
Capitalization177.19M
SYRE vs VTYX Comparison Chart
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. VTYX commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Hold and VTYX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (SYRE: $17.71 vs. VTYX: $2.49)
Brand notoriety: SYRE and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 125% vs. VTYX: 102%
Market capitalization -- SYRE: $1.09B vs. VTYX: $177.19M
SYRE [@Biotechnology] is valued at $1.09B. VTYX’s [@Biotechnology] market capitalization is $177.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • SYRE’s TA Score: 5 bullish, 4 bearish.
  • VTYX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both SYRE and VTYX are a good buy in the short-term.

Price Growth

SYRE (@Biotechnology) experienced а +6.56% price change this week, while VTYX (@Biotechnology) price change was +10.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.74%. For the same industry, the average monthly price growth was +15.53%, and the average quarterly price growth was +6.63%.

Reported Earning Dates

SYRE is expected to report earnings on Jul 31, 2025.

VTYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1.09B) has a higher market cap than VTYX($177M). VTYX YTD gains are higher at: 13.699 vs. SYRE (-23.926). VTYX has higher annual earnings (EBITDA): -135.48M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. VTYX (229M). SYRE has less debt than VTYX: SYRE (0) vs VTYX (10.5M). SYRE (0) and VTYX (0) have equivalent revenues.
SYREVTYXSYRE / VTYX
Capitalization1.09B177M614%
EBITDA-214.36M-135.48M158%
Gain YTD-23.92613.699-175%
P/E Ratio1.72N/A-
Revenue00-
Total Cash565M229M247%
Total Debt010.5M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYREVTYX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend about 1 month ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVAIX23.080.06
+0.26%
Calamos Select Fund I
PEOPX59.22N/A
N/A
BNY Mellon S&P 500 Index
PNBCX28.08N/A
N/A
Virtus NFJ Large-Cap Value C
OTCAX29.88N/A
N/A
MFS Mid Cap Growth A
DDERX14.94N/A
N/A
Macquarie Wealth Builder R6

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-1.61%
BEAM - SYRE
57%
Loosely correlated
-2.52%
CGON - SYRE
57%
Loosely correlated
+1.22%
IMNM - SYRE
54%
Loosely correlated
+3.16%
APGE - SYRE
53%
Loosely correlated
-1.37%
XNCR - SYRE
53%
Loosely correlated
-0.95%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with IMNM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+2.05%
IMNM - VTYX
48%
Loosely correlated
+3.16%
IPSC - VTYX
48%
Loosely correlated
-1.01%
KYMR - VTYX
46%
Loosely correlated
-2.27%
SYRE - VTYX
42%
Loosely correlated
-1.61%
KOD - VTYX
42%
Loosely correlated
-8.68%
More